Role of Neoadjuvent Radiotherapy in Locally Advanced Cancer Rectum

NCT04814784 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2021-03-24

No results posted yet for this study

Summary

This is a retrospective study comparing neoadjuvent short course radiotherapy to conventional chemoradiation in locally advanced cancer rectum and the effect of both regimens in overall survival and disease free survival

Conditions

  • Rectal Adenocarcinoma

Interventions

RADIATION

Neoadjuvent radiotherapy either short or long course chemoradiation in treatment of locally advanced cancer rectum

Study the effect of neoadjuvent radiotherapy in treatment of locally advanced cancer rectum e higher possiblity of preservation of anal sphincter and decreased rate of locoregional recurrence compared to surgery alone

Sponsors & Collaborators

  • Amany sayed Abass

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-10-01
Completion
2022-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04814784 on ClinicalTrials.gov